◆英語タイトル:AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C3056
◆発行会社(調査会社):
GlobalData
◆発行日:2018年8月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
AcelRx Pharmaceuticals Inc (ACRX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
AcelRx Pharmaceuticals Inc (AcelRx), is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain. The company’s lead product candidate, Dsuvia (known as Dzuveo outside the US), is a single sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. Its pipeline also includes Zalviso, a drug and device combination product for management of moderate to severe acute pain in adults. AcelRx developed a proprietary, non-invasive, sublingual formulation technology to deliver its highly lipophilic drugs. The company commercializes its EC approved Zalviso under license agreement with Grunenthal in various European Union countries and Australia. AcelRx is headquartered in Redwood City, California, the US.
AcelRx Pharmaceuticals Inc Key Recent Developments
Aug 02,2018: AcelRx Pharmaceuticals reports second quarter 2018 financial results
Jul 11,2018: AcelRx Pharmaceuticals Announces Commencement of Public Offering of Common Stock
May 09,2018: AcelRx Pharmaceuticals Reports First Quarter 2018 Financial Results
Mar 27,2018: AcelRx Pharmaceuticals Names John Saia As General Counsel
Mar 08,2018: AcelRx Pharmaceuticals Reports Fourth Quarter 2017 Financial Results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
AcelRx Pharmaceuticals Inc – Key Facts 6
AcelRx Pharmaceuticals Inc – Key Employees 7
AcelRx Pharmaceuticals Inc – Key Employee Biographies 8
AcelRx Pharmaceuticals Inc – Major Products and Services 10
AcelRx Pharmaceuticals Inc – History 11
AcelRx Pharmaceuticals Inc – Company Statement 12
AcelRx Pharmaceuticals Inc – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Company Overview 14
AcelRx Pharmaceuticals Inc – Business Description 15
R&D Overview 15
AcelRx Pharmaceuticals Inc – Corporate Strategy 16
AcelRx Pharmaceuticals Inc – SWOT Analysis 17
SWOT Analysis – Overview 17
AcelRx Pharmaceuticals Inc – Strengths 17
AcelRx Pharmaceuticals Inc – Weaknesses 18
AcelRx Pharmaceuticals Inc – Opportunities 19
AcelRx Pharmaceuticals Inc – Threats 20
AcelRx Pharmaceuticals Inc – Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios – Capital Market Ratios 22
Financial Ratios – Annual Ratios 23
Performance Chart 25
Financial Performance 25
Financial Ratios – Interim Ratios 26
Financial Ratios – Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
AcelRx Pharmaceuticals Inc, Recent Deals Summary 30
Section 5 – Company’s Recent Developments 31
Aug 02, 2018: AcelRx Pharmaceuticals reports second quarter 2018 financial results 31
Jul 11, 2018: AcelRx Pharmaceuticals Announces Commencement of Public Offering of Common Stock 32
May 09, 2018: AcelRx Pharmaceuticals Reports First Quarter 2018 Financial Results 33
Mar 08, 2018: AcelRx Pharmaceuticals Reports Fourth Quarter 2017 Financial Results 34
Nov 09, 2017: AcelRx Pharmaceuticals Reports Third Quarter 2017 Financial Results 35
Aug 01, 2017: AcelRx Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update 36
Jul 19, 2017: AcelRx Pharmaceuticals Appoints Raffi Asadorian as Chief Financial Officer 38
Jun 01, 2017: AcelRx’s pain management drug selected for Red Dot Design Award 39
May 08, 2017: AcelRx Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update 40
Mar 02, 2017: AcelRx Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results 42
Section 6 – Appendix 44
Methodology 44
Ratio Definitions 44
About GlobalData 48
Contact Us 48
Disclaimer 48
List of Tables
AcelRx Pharmaceuticals Inc, Key Facts 6
AcelRx Pharmaceuticals Inc, Key Employees 7
AcelRx Pharmaceuticals Inc, Key Employee Biographies 8
AcelRx Pharmaceuticals Inc, Major Products and Services 10
AcelRx Pharmaceuticals Inc, History 11
AcelRx Pharmaceuticals Inc, Subsidiaries 13
AcelRx Pharmaceuticals Inc, Key Competitors 21
AcelRx Pharmaceuticals Inc, Ratios based on current share price 22
AcelRx Pharmaceuticals Inc, Annual Ratios 23
AcelRx Pharmaceuticals Inc, Annual Ratios (Cont...1) 24
AcelRx Pharmaceuticals Inc, Interim Ratios 26
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
AcelRx Pharmaceuticals Inc, Recent Deals Summary 30
Currency Codes 44
Capital Market Ratios 44
Equity Ratios 45
Profitability Ratios 45
Cost Ratios 46
Liquidity Ratios 46
Leverage Ratios 47
Efficiency Ratios 47
List of Figures
AcelRx Pharmaceuticals Inc, Performance Chart (2013 - 2017) 25
AcelRx Pharmaceuticals Inc, Ratio Charts 27
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29